Your browser doesn't support javascript.
loading
Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report.
Chen, Shubin; Yu, Qitao; Jiang, Wei; Lu, Yukun; Zhao, Yun; Wang, Huilin.
Afiliação
  • Chen S; Medical Oncology of Respiratory, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Yu Q; Medical Oncology of Respiratory, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Jiang W; Medical Oncology of Respiratory, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Lu Y; Department of Pathology, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Zhao Y; Medical Oncology of Respiratory, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Wang H; Medical Oncology of Respiratory, Guangxi Cancer Hospital, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Front Med (Lausanne) ; 10: 1168220, 2023.
Article em En | MEDLINE | ID: mdl-37457583

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article